HCV Eradication with Direct-Acting Antivirals Does Not Impact HCC Progression on the Waiting List or HCC Recurrence after Liver Transplantation.
Juliet A EmamaulleeMariusz BralGlenda MeebergAldo J Montano-LozaVincent G BainKelly Warren BurakDavid L BigamA M James ShapiroNorman KnetemanPublished in: Canadian journal of gastroenterology & hepatology (2019)
These data suggest that HCV eradication pre-LT does not significantly impact waitlist time for HCV+ patients with HCC. HCV eradication does not impact rates of delisting for HCC progression or rates of HCC recurrence post-LT.